Powell Tribune: ‘Wrongful death’ — Mother of Tranyelle Harshman sues local ketamine provider

During a July 2024 workshop hosted by the Reagan-Udall Foundation for the FDA, Dr. Gerard Sanacora of the Yale University Depression Research Program said ketamine has spurred a lot of excitement, “but I think it really speaks to the desperation of patients suffering from severe treatment resistant depression, and the desperation of the clinicians trying to treat them.”